Kevin K. Roggin to Survival Analysis
This is a "connection" page, showing publications Kevin K. Roggin has written about Survival Analysis.
Connection Strength
0.254
-
D3 or not D3... that is not the question. Lancet Oncol. 2006 Apr; 7(4):279-80.
Score: 0.053
-
Limitations of ampullectomy in the treatment of nonfamilial ampullary neoplasms. Ann Surg Oncol. 2005 Dec; 12(12):971-80.
Score: 0.052
-
High neutrophil-lymphocyte ratio is not independently associated with worse survival or recurrence in patients with extremity soft tissue sarcoma. Surgery. 2020 10; 168(4):760-767.
Score: 0.036
-
Outcomes of palliative-intent surgery in retroperitoneal sarcoma-Results from the US Sarcoma Collaborative. J Surg Oncol. 2020 Jun; 121(7):1140-1147.
Score: 0.035
-
Orthotopic liver transplantation provides a survival advantage compared with resection in patients with hepatocellular carcinoma and preserved liver function. Surgery. 2017 11; 162(5):1032-1039.
Score: 0.029
-
Comparison of tumor markers for predicting outcomes after resection of nonfunctioning pancreatic neuroendocrine tumors. Surgery. 2014 Dec; 156(6):1504-10; discussion 1510-1.
Score: 0.024
-
Differential cell cycle-regulatory protein expression in biliary tract adenocarcinoma: correlation with anatomic site, pathologic variables, and clinical outcome. J Clin Oncol. 2006 Mar 01; 24(7):1152-60.
Score: 0.013
-
Papillary phenotype confers improved survival after resection of hilar cholangiocarcinoma. Ann Surg. 2005 May; 241(5):703-12; discussion 712-4.
Score: 0.012